Abstract:Introduction Left ventricular assist devices (LVADs) are indicated for patients with Stage D heart failure with reduced ejection fraction (HFrEF). Furthermore, stage D HFrEF is associated with increased hospital admissions. Racial and ethnic disparities in the access LVADs have been described in the past, revealing significant gaps in care. However, it remains to be seen if current efforts to mitigate health disparities have improved access to LVADs in underrepresented populations. Therefore, we aim to clarify existing practices in the United States to examine if there have been any changes in racial disparities in the access to LVADs and use this critical knowledge to direct additional steps to mitigate health disparities. Hypothesis Racial disparities exist in the access to LVADs in the US. Methods The National Inpatient Sample (NIS) was queried from 2016 to 2019 to identify all adult admissions with HFrEF who underwent LVAD placement using the International Classification of Diseases Tenth Revision (ICD-10) codes. We stratified the sample into 3 study groups: Black, Hispanic, and White. We explored baseline characteristics, LVAD utilization (defined as the number of LVADs per 100,000 admissions with a history of HFrEF) and completed a multivariate regression analysis to assess the association of race and ethnicity with LVAD placement and clinically meaningful outcomes. Results A total of 7,674,108 admissions with HFrEF were included study, and 14,665 (0.2%) underwent LVAD placement. Seventy-seven percent of patients who received an LVAD were male. Black patients were likelier to be of lower socioeconomic status and be enrolled in Medicaid than Hispanic and White patients. LVAD utilization was higher in Black patients compared to White and Hispanic patients (256 vs. 175 vs. 175, respectively, p<0.001). Compared to White race, Black race had higher odds of receiving an LVAD (OR=1.60, 95% CI 1.41-1.80, p<0.001), receiving a blood transfusion (OR=1.40, 95% CI 1.05-1.84, p=0.02), and non-routine discharge (OR=1.35, 95% CI 1.09-1.67, p=0.006). Hispanic race was associated with lower odds of survival free of stroke (OR=0.68, 0.47-0.98, p=0.038) compared to White race. However, there was no difference in mortality between the study groups. Conclusion Black race was associated with higher odds of LVAD utilization after adjusting for multiple confounders. Compared to previous studies, inequalities in outcomes remain while an apparent disparity in the access to LVADs in Black patients is not evident in this study which might be related to potential confounders or other factors. Further studies evaluating both outcomes are needed to clarify the reasons behind these findings.

Social Determinants of Health and Outcomes After Pediatric Ventricular Assist Device Implantation

Mechanical Ventilation and Outcomes of Children Who Undergo Ventricular Assist Device Placement: 2014–2020 Linked Analysis From the Advanced Cardiac Therapies Improving Outcomes Network and Pediatric Cardiac Critical Care Consortium Registries

Impact of center volume on outcomes after ventricular assist device implantation in pediatric patients: An analysis of the STS-Pedimacs database

Impact of ventricular assist device use on pediatric heart transplant waitlist mortality: Analysis of the scientific registry of transplant recipients database

Child Opportunity Index and Pediatric Extracorporeal Membrane Oxygenation Outcomes; the Role of Diagnostic Category

Impact of Patient Distance From Ventricular Assist Device–Implanting Center on Short- and Long-Term Outcomes

Association between psychosocial factors and left ventricular assist device implant outcomes: A systematic review

Clinical Application and Choice of Mechanical Circulatory Support Devices in Children

Comparative analysis of regional outcomes and adverse events after continuous-flow left ventricular assist device implantation: An IMACS analysis

Ventricular assist device support in paediatric patients with restrictive cardiomyopathy - Clinical outcomes and haemodynamics

Durable left ventricular assist devices in pediatrics: impact of body size on outcomes and size limitations

Impact of Social Determinants of Health on Predictive Models for Outcomes After Congenital Heart Surgery

Outcomes of Intracorporeal Continuous and Paracorporeal Pulsatile Ventricular Assist Devices in Pediatric Patients 10–30 kg

Racial And Ethnic Disparities In The Contemporary Utilization Of Left Ventricular Assist Devices In The United States

Assessing The Outcomes In Black Women Patients Following Left Ventricular Assist Device Implantation: Representation Through A Single Center Analysis

Racial Health Disparity Associated With Poor Pediatric Cardiac Surgery Outcomes: A Multicentered, Cross-Sectional Study

Socioeconomic Influences on Outcomes Following Congenital Heart Disease Surgery

Abstract 15760: Survival Following Durable Ventricular Assist Device Implantation is Associated With Provider Teamwork: A Social Network Analysis

Association of Psychosocial Risk Factors With Quality of Life and Readmissions 1-Year After LVAD Implantation

Age and gender differences and factors related to change in health-related quality of life from before to 6 months after left ventricular assist device implantation: Findings from Interagency Registry for Mechanically Assisted Circulatory Support

Single Ventricular Assist Device Care and Outcomes for Failed Stage I Palliation: A Single-Center Decade of Experience